1887

Microbiology Society logo

Volume 144, Issue 2

Streptococcus suis serotype 2 mutants deficient in capsular expression Free

Abstract

serotype 2 is responsible for a wide variety of porcine infections. In addition, it is considered a zoonotic agent. Knowledge about the virulence factors for this bacterium is limited but its polysaccharide capsule is thought to be one of the most important. Transposon mutagenesis with the self-conjugative transposon Tn was used to obtain acapsular mutants from the virulent type 2 reference strain S735. Clones were screened by colony-dot ELISA with a monoclonal antibody specific for a type 2 capsular epitope and clones that failed to react with the antibody were characterized. Two mutants, 2A and 79, having one and two Tn insertions respectively, were chosen for further characterization. Absence of capsule was confirmed by coagglutination, capillary precipitation and capsular reaction tests and by transmission electron microscopy. Absence of capsular polysaccharides correlated with increased hydrophobicity and phagocytosis by both murine macrophages and porcine monocytes compared to the wild-type strain. Furthermore, both mutants were shown to be avirulent in murine and pig models of infection. Finally, mutant 2A was readily eliminated from circulation in mice compared to the wild-type strain, which persisted more than 48 h in blood. Thus, isogenic mutants defective in capsule production demonstrate the importance of capsular polysaccharides as a virulence factor for type 2.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): capsule , mutant , Streptococcus suis and Tn916
© Society for General Microbiology 1998
Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-144-2-325
1998-02-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/micro/144/2/mic-144-2-325.html?itemId=/content/journal/micro/10.1099/00221287-144-2-325&mimeType=html&fmt=ahah

References

  1. Absolom R. 1988; The role of bacterial hydrophobicity in infection: bacterial adhesion and phagocytic ingestion.. Can J Microbiol 34:287–298
     [Google Scholar]
  2. Arends J. P., Zanen H. 1988; Meningitis caused by Streptococcus suis in humans.. Rev Infect Dis 10:131–137
     [Google Scholar]
  3. Beaudoin M., Higgins R., Harel J., Gottschalk M. 1992; Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates.. FEMS Microbiol Lett 78:111–116
     [Google Scholar]
  4. Brazeau C., Vincelette S., Gottschalk M., Martineau-Doizè B. 1996; In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages.. Microbiology 142:1231–1237
     [Google Scholar]
  5. Caparon M. G., Scott J. R. 1987; Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci.. Proc Natl Acad Sci USA 84:8677–86
     [Google Scholar]
  6. Caparon M. G., Scott J. R. 1991; Genetic manipulation of pathogenic streptococci.. Methods Enzymol 204:556–586
     [Google Scholar]
  7. Charland N., Kellens J. T. C., Caya F., Gottschalk M. 1995; Agglutination of Streptococcus suis by sialic acid-binding lectins.. J Clin Microbiol 33:2220–2221
     [Google Scholar]
  8. Charland N., Kobisch M., Martineau-Doiz B., Jacques M., Gottschalk M. 1996; Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2.. FEMS Immunol Med Microbiol 14:195–203
     [Google Scholar]
  9. Charland N., Jacques M., Lacouture S., Gottschalk M. 1997; Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2.. Microbiology 143:3607–3614
     [Google Scholar]
  10. Clifton-Hadley F. A. 1981 Studies of Streptococcus suis type 2 infection in pigs PhD thesis University of Cambridge;
     [Google Scholar]
  11. Dale J. B., Washburn R. G., Marques M. B., Wessels M. R. 1996; Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.. Infect Immun 64:1495–1501
     [Google Scholar]
  12. Elliott S. D., Tai J. 1978; The type-specific polysaccharides of Streptococcus suis . J Exp Med 148:1699–1704
     [Google Scholar]
  13. Elliott S. D., Clifton-Hadley F. A., Tai J. 1980; Streptococcal infection in young pigs. V. An immunogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against streptococcal meningitis in pigs.. J Hyg 85:275–285
     [Google Scholar]
  14. Flannagan S. E., Zitzow L. A., Su Y. A., Clewell D. B. 1994; Nucleotide sequence of the 18-kb conjugative transposon Tn916 from Enterococcus faecalis . Plasmid 32:350–354
     [Google Scholar]
  15. Gawron-Burke C., Clewell D. B. 1984; Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: strategy for targeting and cloning of genes from Gram-positive bacteria.. J Bacteriol 159:214–221
     [Google Scholar]
  16. Gottschalk M., Higgins R., Jacques M., Dubreuil D. 1992; Production and characterization of two Streptococcus suis capsular type 2 mutants.. Vet Microbiol 30:59–71
     [Google Scholar]
  17. Gottschalk M., Lacouture S., Dubreuil J. D. 1995; Characterization of Streptococcus suis capsular type 2 haemolysin.. Microbiology 141:189–195
     [Google Scholar]
  18. Gottschalk M., Lebrun A., Wisselink H., Dubreuil J. D., Smith H., Vecht U. 1998; Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2.. Can J Vet Res 62:75–79
     [Google Scholar]
  19. Higgins R., Gottschalk M. 1990; An update on Streptococcus suis identification.. J Vet Diagn Invest 2:249–252
     [Google Scholar]
  20. Higgins R., Gottschalk M. 1996; Distribution of Streptococcus suis capsular types in 1995.. Can Vet J 37:242
     [Google Scholar]
  21. Higgins R., Gottschalk M. 1998 Streptococcal diseases.. In Diseases of Swine chapter 38 Iowa: Iowa State University Press; (in press)
    [Google Scholar]
  22. Jacobs A. A. C., Loeffen P. L. W., Van Den Berg A. J. G., Storm P. K. 1994; Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis . Infect Immun 62:1742–1748
     [Google Scholar]
  23. Jacques M., Gottschalk M., Foiry B., Higgins R. 1990; Ultrastructural study of surface components of Streptococcus suis . J Bacteriol 172:2833–2838
     [Google Scholar]
  24. Kasper D. L. 1986; Bacterial capsule – old dogmas and new tricks.. J Infect Dis 153:407–415
     [Google Scholar]
  25. Katsumi M., Saito T., Kataoka Y., Itoh T., Kikuchi N., Hiramune T. 1996; Comparative preparation methods of sialylated capsule antigen from Streptococcus suis type 2 with type specific antigenicity.. J Vet Med Sci 58:947–952
     [Google Scholar]
  26. Kim K. S., Itabashi H., Gemski P., Sadoff J., Warren R. L., Cross A. S. 1992; The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.. J Clin Invest 90:897–905
     [Google Scholar]
  27. Martin T. R., Ruzinski J. T., Rubens C. E., Chi E. Y., Wilson C. B. 1992; The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.. J Infect Dis 165:306–314
     [Google Scholar]
  28. Moxon E. R., Kroll J. S. 1990; The role of bacterial polysaccharide capsules as virulence factors.. Curr Top Microbiol Immunol 150:65–85
     [Google Scholar]
  29. Nizet V., Gibson R. L., Chi E. Y., Framson P. E., Hulse M., Rubens C. E. 1996; Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells.. Infect Immun 64:3818–3826
     [Google Scholar]
  30. Quessy S., Dubreuil J. D., Caya M., Higgins R. 1995; Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.. Infect Immun 63:1975–1979
     [Google Scholar]
  31. Reed L J., Muench H. 1938; A simple method of estimating the fifty percent endpoints.. Am J Hyg 27:493–97
     [Google Scholar]
  32. Rioux S., Bègin C., Dubreuil J. D., Jacques M. 1997; Isolation and characterization of LPS mutants of Actinobacillus pleuro-pneumoniae serotype 1.. Curr Microbiol 35:139–144
     [Google Scholar]
  33. Rosenberg M. 1984; Bacterial adherence to hydrocarbons: a useful technique for studying cell-surface hydrophobicity.. FEMS Microbiol Lett 22:289–295
     [Google Scholar]
  34. Rubens C. E., Wessels M. R., Heggen L. M., Kasper D. L. 1987; Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.. Proc Natl Acad Sci USA 84:7208–7212
     [Google Scholar]
  35. Rubens C. E., Heggen L. M., Haft R. F., Wessels M. R. 1993; Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.. Mol Microbiol 8:843–855
     [Google Scholar]
  36. Salasia S. I. O., LSmmler C., Herrmann G. 1995; Properties of a Streptococcus suis isolate of serotype 2 and two capsular mutants.. Vet Microbiol 45:151–156
     [Google Scholar]
  37. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual 2nd edn Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
     [Google Scholar]
  38. Smith H. E., Vecht U., Wisselink H. J., Stockhofe-Zurwieden N., Biermann Y., Smits M. A. 1996; Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs.. Infect Immun 64:4409–4412
     [Google Scholar]
  39. Tikkanen K., Haataja S., Finne J. 1996; The galactosyl-(α1−4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies.. Infect Immun 64:3659–3665
     [Google Scholar]
  40. Trottier S., Higgins R., Brochu G., Gottschalk M. 1991; A case of human endocarditis due to Streptococcus suis in North America.. Rev Infect Dis 13:1251–1252
     [Google Scholar]
  41. Vecht U., Wisselink H. J., Jellema M. L., Smith H. E. 1991; Identification of two proteins associated with virulence of Streptococcus suis type 2.. Infect Immun 59:3156–3162
     [Google Scholar]
  42. Walsh B., Williams A. E., Satsangi J. 1992; Streptococcus suis type 2: pathogenesis and clinical disease.. Rev Med Microbiol 3:65–71
     [Google Scholar]
  43. Warren L. 1963; Thiobarbituric acid assay of sialic acids.. Methods Enzymol 6:463–464
     [Google Scholar]
  44. Wessels M. R., Moses A. E., Goldberg J. B., DiCesare T. J. 1991; Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.. Proc Natl Acad Sci USA 88:8317–8321
     [Google Scholar]
  45. Williams A. E. 1990; Relationship between intracellular survival in macrophages and pathogenicity of Streptococcus suis type 2 isolates.. Microb Pathog 8:189–196
     [Google Scholar]
  46. Williams A. E., Blakemore W. F., Alexander T. J. 1988; A murine model of Streptococcus suis type 2 meningitis in the pig.. Res Vet Sci 45:394–399
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-144-2-325
Loading
Streptococcus suis serotype 2 mutants deficient in capsular expression
Microbiology 144, 325 (1998); https://doi.org/10.1099/00221287-144-2-325
/content/journal/micro/10.1099/00221287-144-2-325
/content/journal/micro/10.1099/00221287-144-2-325
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error